Computer firms lead R&D spending

Top companies spent £289bn on research and development in 2007 with computer-related firms leading the way.

Management consultant Booz & Company analysed 1,000 firms that spent the most on R&D. Booz & Company found the 2007 growth rate in R&D spending was well over the compound growth rate of 6.7%.

Download this free guide

Infographic: Future-proofing UK technology

The current potential of the UK technology industry is restricted by the lack of tech and digital talent available. Read through this challenge for the future of UK business and our economy.

Start Download

• Corporate E-mail Address:

  You forgot to provide an Email Address.

  This email address doesn’t appear to be valid.

  This email address is already registered. Please login.

  You have exceeded the maximum character limit.

  Please provide a Corporate E-mail Address.

By submitting my Email address I confirm that I have read and accepted the Terms of Use and Declaration of Consent.

By submitting your personal information, you agree that TechTarget and its partners may contact you regarding relevant content, products and special offers.

You also agree that your personal information may be transferred and processed in the United States, and that you have read and agree to the Terms of Use and the Privacy Policy.

Two-thirds of R&D spending was concentrated in just three industries in 2007: computing and electronics (29%), health (22%) and automotive (16%).

The top 10 global R&D spenders in 2007 were, in descending order: Toyota, General Motors, Pfizer, Nokia, Johnson & Johnson, Ford, Microsoft, Roche Holding AG, Samsung Electronics and GlaxoSmithKline. Number one spender Toyota spent £4.9bn.

Most of the 1,000 companies (91%) conducted R&D activities in countries outside the nation where they were headquartered.

Companies which spent more than 60% of their R&D budget outside their home countries over the past three years, appeared to enjoy better performance in total shareholder return, operating margin, market cap growth and return on assets, said Booz and Company.

Out of the 1,000 companies analysed, only two British companies, GlaxoSmithKline and Astra Zeneca - both in the health sector - were among the top 20 R&D spenders.

John Potter, partner at Booz and Company, said: "Investment in R&D in the UK is crucial for the country to remain competitive."

Bristol University drives R&D with £7m super computer